111 related articles for article (PubMed ID: 2271749)
21. [Influence of active antiarrhythmia substances on refractory period and contractility of guinea pig atria].
Heeg E; Reuter N; Steiger H
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):244-5. PubMed ID: 4243341
[No Abstract] [Full Text] [Related]
22. Lack of relationship between quinidine pharmacokinetics and the sparteine oxidation polymorphism.
Nielsen F; Rosholm JU; Brøsen K
Eur J Clin Pharmacol; 1995; 48(6):501-4. PubMed ID: 8582470
[TBL] [Abstract][Full Text] [Related]
23. Microbial biotransformation of retinoic acid by Cunninghamella echinulata and Cunninghamella blakesleeana.
Hartman DA; Basil JB; Robertson LW; Curley RW
Pharm Res; 1990 Mar; 7(3):270-3. PubMed ID: 2339101
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the pharmacokinetic and pharmacodynamic interaction between quinidine and nifedipine.
Bowles SK; Reeves RA; Cardozo L; Edwards DJ
J Clin Pharmacol; 1993 Aug; 33(8):727-31. PubMed ID: 8408733
[TBL] [Abstract][Full Text] [Related]
25. Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.
Inaba T; Tyndale RE; Mahon WA
Br J Clin Pharmacol; 1986 Aug; 22(2):199-200. PubMed ID: 3756068
[No Abstract] [Full Text] [Related]
26. Microbial transformation of dextromethorphan by Cunninghamella blakesleeana AS 3.153.
Lin L; Huang H; Zhang P; Qi X; Zhong D
Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):658-61. PubMed ID: 17409567
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine.
Mikus G; Ha HR; Vozeh S; Zekorn C; Follath F; Eichelbaum M
Eur J Clin Pharmacol; 1986; 31(1):69-72. PubMed ID: 3780830
[TBL] [Abstract][Full Text] [Related]
28. [Screening tests of microorganisms for the microbial transformation of griseophenone A, N-methylcoclaurine and sparteine].
Isaka H; Minemura Y; Iida M; Okuda S; Iizuka H
Eisei Shikenjo Hokoku; 1970; 88():144-9. PubMed ID: 6015286
[No Abstract] [Full Text] [Related]
29. Unexpected interaction between CYP3A4 and BI 11634: is BI 11634 interacting with CYP3A4 similar to nifedipine?
Mathur A; Tweedie DJ; Maw HH; Li Y
Drug Metabol Drug Interact; 2013; 28(4):239-46. PubMed ID: 24166670
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of alkaloids on sodium currents of isolated single skeletal muscle fibers.
Körper S; Wink M; Fink RH
FEBS Lett; 1998 Oct; 436(2):251-5. PubMed ID: 9781689
[TBL] [Abstract][Full Text] [Related]
31. Oral ethanol ingestion altered nifedipine pharmacokinetics in the rat: a preliminary study.
Boje KM; Dolce JA; Fung HL
Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):219-26. PubMed ID: 6515116
[TBL] [Abstract][Full Text] [Related]
32. Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugs.
Otton SV; Inaba T; Kalow W
Life Sci; 1984 Jan; 34(1):73-80. PubMed ID: 6141510
[TBL] [Abstract][Full Text] [Related]
33. Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes.
Otton SV; Crewe HK; Lennard MS; Tucker GT; Woods HF
J Pharmacol Exp Ther; 1988 Oct; 247(1):242-7. PubMed ID: 3171974
[TBL] [Abstract][Full Text] [Related]
34. Sparteine metabolism capacity in human liver: structural variants of human P450IID6 as assessed by immunochemistry.
Tyndale RF; Gonzalez FJ; Hardwick JP; Kalow W; Inaba T
Pharmacol Toxicol; 1990 Jul; 67(1):14-8. PubMed ID: 2395811
[TBL] [Abstract][Full Text] [Related]
35. Novel microbial transformations of sclareolide.
Ata A; Conci LJ; Betteridge J; Orhan I; Sener B
Chem Pharm Bull (Tokyo); 2007 Jan; 55(1):118-23. PubMed ID: 17202714
[TBL] [Abstract][Full Text] [Related]
36. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
Brøsen K; Gram LF
Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
[TBL] [Abstract][Full Text] [Related]
37. Influence of enzyme induction and inhibition on the oxidation of nifedipine, sparteine, mephenytoin and antipyrine in humans as assessed by a "cocktail" study design.
Schellens JH; van der Wart JH; Brugman M; Breimer DD
J Pharmacol Exp Ther; 1989 May; 249(2):638-45. PubMed ID: 2724144
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic interactions of nifedipine and quinidine.
Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of phencyclidine by microorganisms.
Hufford CD; Baker JK; Clark AM
J Pharm Sci; 1981 Feb; 70(2):155-8. PubMed ID: 7205218
[TBL] [Abstract][Full Text] [Related]
40. Comparative effects of sparteine and quinidine on isolated frog heart.
LU G
Fed Proc; 1948 Mar; 7(1 Pt 1):241. PubMed ID: 18938566
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
